 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
 |
|||||||||
|
|||||||||
|
|||||||||
New eNewsletter Archive
MenopauseRx has created an easy to use archive of our latest newsletters for quick and easy review.
Here you’ll find past issues of our member’s only newsletters that contain news and study information related to your menopausal transition.
Breaking News… on New Mammogram Recommendations
The medical staff at MenopauseRx, Inc. is more than a little surprised by the new recommendations of the U.S. Preventive Services Task Force (USPSTF). For the first time in 20 years, a government panel is telling women in there 40s to stop getting routine mammograms. The MenopauseRx staff is not alone in questioning these new guidelines. Many medical centers, breast cancer survivors, and thousands of health care providers, including doctors, are upset with these new recommendations.
Why did the USPSTF recommendations change?
PITTSBURGH – – Although an increasing number of people are taking powerful new prescription drugs to treat osteoporosis, chances are the majority of patients are not getting the greatest effect from these medicines because they do not have an adequate calcium and vitamin D intake, according to a paper published in the March 2005 issue of The Journal of Women’s Health. John A. Sunyecz, M.D., president of MenopauseRx, Inc., who co-authored the paper, “Calcium’s Role in Osteoporosis Drug Therapy,” notes that many people being treated for osteoporosis mistakenly think their calcium and vitamin D intake is no longer important once prescription therapy begins. “People taking osteoporosis medications should remember that they do not contain calcium and have been proven most effective when taken with adequate calcium and vitamin D, usually achieved with the addition of supplements to the daily diet,” he explains.
“This paper builds on previous research published last year that shows physicians are not taking the clinical information we know about these drugs and putting it into practice when treating patients. From 1994 to 2003 there was a five-fold increase in prescriptions for bisphosphonates, however during that same time period, the percentage of osteoporosis patients who were treated with calcium supplements decreased by nearly 50 percent.”
The American Heart Association has updated its recommendation regarding hormone replacement therapy (HRT). Their current recommendation states that physicians should not base the decision to use HRT based upon heart disease prevention. This recommendation is the result of a number of relatively recent studies refuting earlier data about the protective effects of HRT on the cardiovascular system.
Most gynecologists prescribe HRT for the treatment of menopause symptoms, such as hot flashes, vaginal dryness, and sleep disturbances. However, from 1995 until 1999 the American Heart Association had recommended that physicians consider estrogen for all postmenopausal women with cardiovascular disease. Read more…
 |
 |
